Foreign firms expand investment in nation
3 months, 3 weeks ago

Foreign firms expand investment in nation

China Daily  

A view of the booth of Zeiss Group during an expo in Shanghai. Despite global foreign direct investment exhibiting a contraction trend in 2023 due to factors such as sluggish economic growth and geopolitical tensions, China's inbound investment flow remained relatively high in the past decade, said a report released on Wednesday. In the first half of 2024, multinational companies continued to increase their investment in China and optimize their industrial strategies, with nearly 27,000 new foreign-funded enterprises registered in China, a year-on-year growth of 14.2 percent, according to the report, titled "Multinationals in China: Sharing New Opportunities of Chinese Modernization". "The third plenary session of the 20th Central Committee of the Communist Party of China proposed a number of high-level measures for further opening up to the outside world and important initiatives to build new high-quality productive forces, further strengthening our confidence and determination to deeply cultivate China for long-term development," Leon Wang, executive vice-president of AstraZeneca, said at the summit. "The center will support the development of all our brands and categories in China and strengthen capabilities to drive competitive advantage and honorable differentiation," said Arjun Purkayastha, senior vice-president and managing director of Reckitt China, adding that it will test new products in China first and later market them to the rest of the world.

History of this topic

AstraZeneca announces plans for new innovations for China
2 months, 3 weeks ago
AstraZeneca staff detained in China amid claims of illegal drug imports
3 months, 2 weeks ago
Foreign firms expand investment in nation
3 months, 3 weeks ago
Annual big event brings huge opportunities to Qingdao
3 months, 3 weeks ago
Med-tech of China gaining popularity
7 months, 1 week ago
China's medical technology shows world-leading signs in some fields
7 months, 1 week ago
AstraZeneca returning for sixth successive expo
1 year, 1 month ago
Firms bullish on scope of China market
1 year, 2 months ago
AstraZeneca expands investment in Qingdao
1 year, 3 months ago
AstraZeneca plots to sell AI drug unit to the Chinese
1 year, 6 months ago
Shandong strengthens ties with pharmaceutical giants
1 year, 9 months ago
AstraZeneca gives rare diseases new challenge
1 year, 9 months ago
7 AstraZeneca projects to settle in Qingdao
2 years, 1 month ago

Discover Related